Shanghai, China

Tao Xue

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Tao Xue

Introduction

Tao Xue is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical compounds, holding a total of 2 patents. His work focuses on developing innovative solutions for treating various medical conditions.

Latest Patents

Tao Xue's latest patents include an aromatic compound and a preparation method therefor and use thereof. This invention relates to a compound that can be utilized in the treatment of nervous system diseases. The patent details a specific compound, its tautomer, enantiomer, diastereomer, or racemate, and its pharmaceutically acceptable salt. Additionally, he has developed an oxazolidone compound, which has strong anticoagulant activity without affecting thrombin activity. This compound also demonstrates good metabolic characteristics and superior oral bioavailability compared to rivaroxaban.

Career Highlights

Throughout his career, Tao Xue has worked with esteemed organizations such as the Chinese Academy of Sciences and Zhejiang Jutai Pharmaceutical Co., Ltd. His experience in these institutions has allowed him to advance his research and contribute to the pharmaceutical industry.

Collaborations

Tao Xue has collaborated with notable colleagues, including Yushe Yang and Shi Ding. These partnerships have fostered innovation and enhanced the development of his patented compounds.

Conclusion

Tao Xue's contributions to the field of pharmaceuticals through his innovative patents highlight his dedication to advancing medical science. His work continues to impact the treatment of various diseases, showcasing the importance of research and development in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…